Tumor Response

Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
Mizuki Nishino, Maria Gargano, Margaret Suda, Nikhil H Ramaiya, F Stephen Hodi

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 17; DOI: 10.1186/2051-1426-2-17
Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome
Mizuki Nishino, Anita Giobbie-Hurder, Nikhil H Ramaiya, F Stephen Hodi

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 40; DOI: 10.1186/s40425-014-0040-2
ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
Robert G Petit, Ajay Mehta, Minish Jain, Sudeep Gupta, Rajnish Nagarkar, Vijay Kumar, Sumana Premkumar, Rakesh Neve, Subhashini John, Partha Basu

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P92; DOI: 10.1186/2051-1426-2-S3-P92

Main menu